Literature DB >> 7591030

Biochemical subtypes of oligodendrocyte in the anterior medullary velum of the rat as revealed by the monoclonal antibody Rip.

A M Butt1, M Ibrahim, F M Ruge, M Berry.   

Abstract

Oligodendrocytes were studied in the anterior medullary velum (AMV) of the rat using the monoclonal antibody Rip, an oligodendrocyte marker of unknown function. Confocal microscopic imaging of double immunofluorescent labelling with antibodies to Rip and carbonic anhydrase II (CAII) revealed two biochemically and morphologically distinct populations of oligodendrocyte which were either Rip+CAII+ or Rip+CAII-. Double immunofluorescent labelling with Rip and myelin basic protein (MBP) or glial fibrillary acidic protein (GFAP) provided direct evidence that Rip-labelled cells were phenotypically oligodendrocytes and confirmed that Rip did not recognise astrocytes. Oligodendrocytes which were Rip+CAII+ supported numerous myelin sheaths for small diameter axons, whilst Rip+CAII- oligodendrocytes supported fewer myelin sheaths for large diameter axons. Morphologically, Rip+CAII+ oligodendrocytes corresponded to types I or II of classical nomenclature, whilst Rip+CAII- oligodendrocytes corresponded to types III and IV. The results demonstrated a biochemical difference between oligodendrocytes which myelinated small and large diameter fibres.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591030     DOI: 10.1002/glia.440140304

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  23 in total

1.  Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes.

Authors:  Audrey D Lafrenaye; Babette Fuss
Journal:  J Neurochem       Date:  2010-08-19       Impact factor: 5.372

2.  Potential interactions between pericytes and oligodendrocyte precursor cells in perivascular regions of cerebral white matter.

Authors:  Takakuni Maki; Mitsuyo Maeda; Maiko Uemura; Evan K Lo; Yasukazu Terasaki; Anna C Liang; Akihiro Shindo; Yoon Kyung Choi; Akihiko Taguchi; Tomohiro Matsuyama; Ryosuke Takahashi; Masafumi Ihara; Ken Arai
Journal:  Neurosci Lett       Date:  2015-04-30       Impact factor: 3.046

3.  Proteolipid protein regulates the survival and differentiation of oligodendrocytes.

Authors:  X Yang; R P Skoff
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

Review 4.  Cellular mechanisms of neurovascular damage and repair after stroke.

Authors:  Ken Arai; Josephine Lok; Shuzhen Guo; Kazuhide Hayakawa; Changhong Xing; Eng H Lo
Journal:  J Child Neurol       Date:  2011-05-31       Impact factor: 1.987

Review 5.  Recent updates on mechanisms of cell-cell interaction in oligodendrocyte regeneration after white matter injury.

Authors:  Ryo Ohtomo; Ken Arai
Journal:  Neurosci Lett       Date:  2019-11-23       Impact factor: 3.046

6.  Glial-cell cultures from brains of carbonic anhydrase II-deficient mutant mice: delay in oligodendrocyte maturation.

Authors:  W Cammer
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 7.  Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury.

Authors:  Akihiro Shindo; Anna C Liang; Takakuni Maki; Nobukazu Miyamoto; Hidekazu Tomimoto; Eng H Lo; Ken Arai
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

8.  Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion.

Authors:  Melissa W VonDran; Harmandeep Singh; Jean Z Honeywell; Cheryl F Dreyfus
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

9.  Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling.

Authors:  Ken Arai; Eng H Lo
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

10.  Multiple restricted origin of oligodendrocytes.

Authors:  N Spassky; C Goujet-Zalc; E Parmantier; C Olivier; S Martinez; A Ivanova; K Ikenaka; W Macklin; I Cerruti; B Zalc; J L Thomas
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.